Corporate Action10 Jul 2026, 01:02 pm
Novelix Pharma Allots 45.75 Lakh Equity Shares
AI Summary
Novelix Pharmaceuticals Ltd announced the allotment of 45,75,000 equity shares following a board meeting on July 9, 2026. This includes 33,75,000 shares issued upon conversion of warrants to promoter and promoter group holders at ₹20 each, and 12,00,000 shares issued via preferential private placement to non-promoters at ₹57 each. The company received ₹50,625,000 from the warrant conversion. This allotment increases the company's paid-up equity capital.
Key Highlights
- Board approved allotment of 45.75 lakh equity shares.
- 33.75 lakh shares issued upon warrant conversion to promoters.
- 12 lakh shares issued via preferential placement to non-promoters.
- Total paid-up equity capital increased post-allotment.
- Fundraising through equity issuance completed.
Price Impact
More from TRIMURTHI